Paris, Ile-de-France, France Related Funds
| Fund Name | Location |
| Acronym Venture Capital | Florida, Palm Beach, United States |
| Allrise Capital | - |
| Anhui University of Technology | Anhui, China, Maanshan |
| Beijing Boyu Cangqiong Keji Youxian Gongsi | Beijing, Beijing, China |
| Crayhill Capital Management | New York, New York, United States |
| Crowd Capital Ventures LLC | Florida, Miami, United States |
| Enbei Investment | - |
| ET Capital Partners | California, Pleasanton, United States |
| Full Moon Investments | Cary, North Carolina, United States |
| ICG Ventures | La Vergne, Tennessee, United States |
| Keiretsu Capital | Seattle, United States, Washington |
| KOSHIDAKA HOLDINGS | Chiba Prefecture, Japan, Tateyama |
| Merstal Ltd. | - |
| National Research Council of Canada Industrial Research Assistance Program | Canada, Ontario, Ottawa |
| Newchip | Austin, Texas, United States |
| Stellar Development Foundation | California, San Francisco, United States |
| StreamS Capital, LLC | Florida, Tampa, United States |
| TGVest Capital | Taipei, Taiwan |
| Toho Holdings | Japan, Tokyo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Orikine Bio | $6M | 18 Jul 2023 | Barcelona, Catalonia, Spain | ||
Astraveus | $19M | 27 Jun 2023 | Paris, Ile-de-France, France | ||
Anoat Therapeutics | $2M | 19 Jun 2023 | Paris, Ile-de-France, France | ||
DiogenX | $39M | 10 May 2023 | Marseille, Provence-Alpes-Côte d'Azur, France | ||
ARTHEx Biotech | $49M | 03 May 2023 | Valencia, Valencian Community, Spain | ||
Calida Therapeutics | $2M | 06 Apr 2023 | Paris, Ile-de-France, France | ||
Integra Therapeutics | $5M | 02 Dec 2021 | Barcelona, Catalonia, Spain | ||
Agalaia Therapeutics | $4M | 27 Sep 2021 | Paris, Ile-de-France, France | ||
AgomAb Therapeutics | $74M | 10 Mar 2021 | East Flanders |
– AgomAb Therapeutics N.V. announced today the closing of a $74m Series B financing round led by Redmile Group, with participation from Cormorant Asset Management.
– All previous investors also participated in the round, including Advent France Biotechnology, Andera Partners, Boehringer Ingelheim Venture Fund, Omnes Capital, Pontifax, and V-Bio Ventures.
– The proceeds of the Series B will be used to fund clinical proof of concept of the lead program AGMB-101, an HGF-mimetic agonistic antibody, which is currently progressing through IND-enabling studies.
– The capital will also support further growth of the company’s pipeline of drug candidates designed to modulate regenerative pathways to induce functional organ recovery in acute and chronic diseases.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Orikine Bio | $6M | 18 Jul 2023 | Barcelona, Catalonia, Spain | ||
Astraveus | $19M | 27 Jun 2023 | Paris, Ile-de-France, France | ||
Anoat Therapeutics | $2M | 19 Jun 2023 | Paris, Ile-de-France, France | ||
DiogenX | $39M | 10 May 2023 | Marseille, Provence-Alpes-Côte d'Azur, France | ||
ARTHEx Biotech | $49M | 03 May 2023 | Valencia, Valencian Community, Spain | ||
Calida Therapeutics | $2M | 06 Apr 2023 | Paris, Ile-de-France, France | ||
Integra Therapeutics | $5M | 02 Dec 2021 | Barcelona, Catalonia, Spain | ||
Agalaia Therapeutics | $4M | 27 Sep 2021 | Paris, Ile-de-France, France | ||
AgomAb Therapeutics | $74M | 10 Mar 2021 | East Flanders |
